Globally<unk>  resulted in 8,300 deaths in 2013 up from 7,000 deaths in 1990.<unk>  has the highest prevalence in the U.S. and Europe, and is uncommon in Asia and Africa. Worldwide incidence has doubled since the 1960s, with the highest rates of prevalence in Scandinavia, Germany, and New Zealand. Although<unk>  is most common among men aged 15–40 years, it has three peaks: infancy through the age of four as teratomas and yolk sac tumors, ages 25–40 years as post-pubertal seminomas and nonseminomas, and from age 60 as spermatocytic tumors. Germ cell tumors of the testis are the most common<unk>  in young men between the ages of 15 and 35 years. United States In the United States, about 8,900 cases are diagnosed a year. The risk of<unk>  in white men is approximately 4-5 times the risk in black men, and more than three times that of Asian American men. The risk of<unk>  in Latinos and American Indians is between that of white and Asian men. The cause of these differences is unknown. United Kingdom In the UK, approximately 2,000 people are diagnosed a year. Over a lifetime, the risk is roughly 1 in 200 (0.5%). It is the 16th most common<unk>  in men. It accounts for less than 1% of<unk>  deaths in men (around 60 men died in 2012).
Testicular cancer
Epididymitis
Testicular torsion
Spermatocele
Inguinal hernia
Appendix of testis
Hydrocele testis
Hydrocele